Excess Hazard in the Belgian Cancer Population

Slides:



Advertisements
Similar presentations
Introduction Cure models within the framework of flexible parametric survival models T.M-L. Andersson1, S. Eloranta1, P.W. Dickman1, P.C. Lambert1,2 1.
Advertisements

P. Brigger, J. Hoeg, and M. Unser Presented by Yu-Tseh Chi.
Meta-Analysis of PSA Growth Lurdes Y.T. Inoue, Ph.D. Ruth Etzioni, Ph.D. Elizabeth Slate, Ph.D. Christopher Morrel, Ph.D.
Update on the Belgian Cancer Registry, breast cancer data... Belgian Breast Meeting 3-4/10/2008 Liesbet Van Eycken.
Stage-specific survival of screen-detected versus clinically diagnosed colorectal cancer - evidence from the FOBT screening trials- Iris Lansdorp-Vogelaar.
01/20141 EPI 5344: Survival Analysis in Epidemiology Quick Review and Intro to Smoothing Methods March 4, 2014 Dr. N. Birkett, Department of Epidemiology.
Beyond Primary Treatment Professor Jane Maher Joint Chief Medical Officer Macmillan Cancer Support.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.
Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.
Primer on Statistics for Interventional Cardiologists Giuseppe Sangiorgi, MD Pierfrancesco Agostoni, MD Giuseppe Biondi-Zoccai, MD.
Patricia Guyot1,2, Nicky J Welton1, AE Ades1
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.
01/20151 EPI 5344: Survival Analysis in Epidemiology Quick Review from Session #1 March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health &
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
Developed from information included in the AIHW report Cancer in Australia: in brief 2014 Highlights.
Slideset on: Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the.
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
Prediction of lung cancer mortality in Central & Eastern Europe Joanna Didkowska.
Slideset on: Asrani SK, Larson JJ, Yawn B, et al. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013;145: Liver.
Diagnostic Intervals in Breast, Colorectal, Lung, Pancreatic, Oesophageal and Gastric Cancers and : Database Study Richard D NealBangor.
Two-Stage Hepatectomy for Unresectable Metastases :
The Changing Face of Cancer in Iowa
What does the data tell us? Colorectal CANCER IN NEVADA
Ann Intern Med. 2010;153(7): doi: / Figure Legend:
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
Age and Racial/Ethnic Disparities in the Diagnosis of Breast Cancer in an Urban Population Joanne K. Fagan PhD, Denise Fyffe, PhD, Nadine Jenkins, CTR,
Prognostic significance of tumor subtypes in male breast cancer:
Patient Navigation Process
UK Renal Registry 10th Annual Report 2007
Compassionate People World Class Care
(2) - Department of Epidemiology and Population Health, and
Lung cancer is the leading cause of cancer deaths among Ontario women
Lung cancer prevalence on the rise (Nov. 2014)
Prepared by staff in Prevention and Cancer Control.
Mortality rates in incident ESRD patients figure 9
National Resource Center for Late Effects after Cancer Treatment
Lung Cancer Screening: Do Individual Health Beliefs Matter?
Prognosis of younger patients in non-small cell lung cancer
Male and Female Reproductive Health Concerns
It is estimated that about 1
It is estimated that almost 1
6 Cancer survival Ontario Cancer Statistics 2018 Chapter 6: Cancer survival.
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
Cancer in Wales Population incidence of stage at diagnosis Official statistics Published 09:30 hrs 24 November
4 Relative survival Ontario Cancer Statistics 2016 Chapter 4: Relative survival.
Prostate Cancer Screening – Where We Stand now
Volume 384, Issue 9945, Pages (August 2014)
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Aiying Chen, Scott Patterson, Fabrice Bailleux and Ehab Bassily
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Prospective Studies Collaboration Lancet 2009; 373:
The Changing Face of Cancer in Iowa
It is estimated that more than 1
National Cancer Statistics in Korea, 2015
The 10-year cumulative incidence of CRC death or death due to other causes in patients treated with adjuvant chemotherapy after surgery for stages II–III.
LV5FU2-cisplatin followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: Preliminary results of a randomized phase III trial (FFCD.
Chapter 4 SURVIVAL AND LIFE TABLES
ESTIMATING THE EFFICIENCY OF THREE NATIONAL CANCER SCREENING PROGRAMMES USING THE POPULATION-BASED CANCER REGISTRY DATA IN SLOVENIA Vesna ZADNIK MD,
Colorectal cancer survival disparities in California
Nadia Howlader, PhD National Cancer Institute
A: Probability of SICH by baseline glucose level.
Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.
The European population from 1950 to 2050, with estimated population before 2006 (light background) and projected population (dark background). The European.
Proton Therapy for Thymic Malignancies: Multi-institutional Patterns-of-Care and Early Clinical Outcomes from the Proton Collaborative Group Registry &
This tutorial was produced for Canadian Cancer Statistics 2019
Survival of End Stage Renal Failure Patients with Cancer
ANALYZING TUMOR GROWTH
Representativeness of linked cancer registry and dispensed prescription data as compared with cancer registry data alone, by key patient and tumour characteristics.
Presentation transcript:

Excess Hazard in the Belgian Cancer Population Geert Silversmit IACR2019, Vancouver Geert Silversmit, BCR, 2019/06/12

Outline Excess hazard Method used and illustration Results Conclusion

Excess hazard (EH) l = l0 + le Observed/Overall Survival important cancer measure Cancer patients have additional death hazard due to disease, compared to cancer-free persons Total death hazard is sum of Background hazard (as experienced by the “general population”), l0, and the excess hazard due to having the cancer, le. l = l0 + le

Estimating excess hazard (EH) 9/12/2019 Estimating excess hazard (EH) For population-based studies: mostly Relative Survival approaches BCR uses actuarial approach with Ederer II matching  step function for EH Goal: model EH as a continuous function of time and age Method applied: Remontet et al (Stat in Medicine, 2007) Implemented in the R function flexrsurv() Additive total hazard BCR uses actuarial approach with Ederer II matching to the general population, age and time categorised in broad intervals.

Estimating excess hazard (EH) 9/12/2019 Estimating excess hazard (EH) Method applied: Remontet et al (Stat in Medicine, 2007) Implemented in the R function flexrsurv() On the log(le) scale Splines to model time and age as continuous functions Non-linearity (NL) and non-proportionality (NPH) can be considered A cascade of LRT can be used to decide on NL and NPH for age Remontet et al. advice time knots at 1 and 5 year and age knot at mean age.  for descriptive purposes optimised knot positions BCR uses actuarial approach with Ederer II matching to the general population, age and time categorised in broad intervals.

Data Belgian Cancer Registry Incidence period 2004-2016 Belgian residents Vital status at 1 July 2018 Censored at 12 years of FU, too large SE Cancer sites: Pancreas (N=18,440) Oesophagus (N=17,242) Colorectal (N= 104,935) Lung (N= 99,296) Female Breast (N= 132,451)

Illustration On Pancreatic cancer Step function to explore, without age Baseline le(t) function: Optimise time knot(s) all ages combined Within 3 broad age groups Decide on common set time knot(s) Add continuous age: Optimise age knot Final fit Compare weighted predicted curves with step function

Pancreas – all ages, step function

Pancreas – all ages, optimise time knot

Pancreas – optimal time knot position All ages: 2.6 year ≤49 years: 1.2 year 50-64 years: 1.4 year 65+ years: >1.2 year  picked 1.2 year

Pancreas – optimal age knot Trying out deciles of the age at diagnosis distribution Optimal: 60 years

Pancreas – final results Calculate predicted EH curves per age value

Pancreas – final results Weighted predicted age curves, compared to step function for broad age groups

Pancreas – final results Age at diagnosis q1 med q3 66 75 81 61 69 77 58 66 74 53 63 70

Oesophagus 1 time knot: 1.1 year age knot: 57 year

Oesophagus Age at diagnosis q1 med q3 63 73 81 59 67 76 58 66 74 57 63 70

Colorectal 2 time knots: 0.6 & 3.0 year age knot: 54 year

Colorectal Age at diagnosis q1 med q3 73 80 85 66 75 82 67 75 81 59 67

Lung 3 time knots: 0.5, 1.0 & 6.0 year age knot: 54 year 2010-2016

Lung Age at diagnosis q1 med q3 63 72 79 60 68 75 60 68 75 57 64 71

Breast 2 time knots: 0.6 & 3.0 year age knot: 75 year 2004-2014

Breast Age at diagnosis q1 med q3 69 79 85 62 75 83 59 72 80 50 59 68

Wrap up Excess hazard as function of survival time and age Higher EH for older patients EH high first half year since diagnosis, decreases with time Early deaths (<0.5 yrs): higher fractions of advanced stage Less treatments with curative intent Long survivors (>2 yrs): Staging and treatment distribution close to patients still alive

The end

Splines Data range split in k intervals Polynomial fit of degree l in each interval Constrains at the knot to make function smooth, up to (l-1)th derivative order Example 1 knot at t1, degree 2 Continuity in t1: q0=0 Continuity 1st derivative in t1: q1=0

Splines order 2 knot at t=5 black: no constraints blue: continuity red: 1st derivative